Aldesulfone sodium: Difference between revisions
Appearance
Content deleted Content added
removed Category:Sodium compounds; added Category:Organic sodium salts using HotCat |
Structure without blank background. |
||
Line 3: | Line 3: | ||
| verifiedrevid = 477314858 |
| verifiedrevid = 477314858 |
||
| IUPAC_name = [4-[4-(sulfinomethylamino) phenyl] sulfonylphenyl] aminomethanesulfinic acid |
| IUPAC_name = [4-[4-(sulfinomethylamino) phenyl] sulfonylphenyl] aminomethanesulfinic acid |
||
| image = |
| image = Sulfoxone.png |
||
| alt = Skeletal formula of aldesulfone sodium |
| alt = Skeletal formula of aldesulfone sodium |
||
| width = 240 |
| width = 240 |
Revision as of 12:15, 12 March 2020
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | |
Pharmacokinetic data | |
Protein binding | 69% |
Metabolism | Hepatic |
Elimination half-life | 3 to 8 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C14H16N2Na2O6S3 |
Molar mass | 404.485 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Aldesulfone sodium (or sulfoxone) is an antibiotic used in the treatment of leprosy.
Sulfoxone sodium was introduced in Japan in 1948.[1]
References